Safety of veliparib in combination with chemotherapy and as maintenance in front-line ovarian cancer: Results in BRCAm, hrd, and whole populations from the velia trial

E. M. Swisher; R. L. Coleman; M. A. Bookman; M. F. Brady; G. F. Fleming; M. Friedlander; M. J. Cunningham; K. S. Tewari; B. Edraki; K. Moxley; G. M. Mantia-Smaldone; C. Ratajczak; M. H. Dinh; D. M. Sullivan; S. McClain; S. Okubo; K. D. Steffensen; C. Aghajanian

doi:10.1016/j.ygyno.2020.06.040

Safety of veliparib in combination with chemotherapy and as maintenance in front-line ovarian cancer: Results in BRCAm, hrd, and whole populations from the velia trial

E. M. Swisher
, R. L. Coleman
, M. A. Bookman
, M. F. Brady
, G. F. Fleming
, M. Friedlander
, M. J. Cunningham
, K. S. Tewari
, B. Edraki
, K. Moxley
, G. M. Mantia-Smaldone
, C. Ratajczak
, M. H. Dinh
, D. M. Sullivan
, S. McClain
, S. Okubo
, K. D. Steffensen
, C. Aghajanian

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Artikelnummer	37
Tidsskrift	Gynecologic Oncology
Vol/bind	159
Udgave nummer	Suppl. 1
Sider (fra-til)	20-21
Antal sider	2
ISSN	0090-8258
DOI	https://doi.org/10.1016/j.ygyno.2020.06.040
Status	Udgivet - 1. okt. 2020
Begivenhed	51st Annual Meeting of the Society of Gynecologic Oncology: Canncelled due to Covid-19 - Varighed: 28. mar. 2020 → …

Konference

Konference	51st Annual Meeting of the Society of Gynecologic Oncology
Periode	28/03/2020 → …

Dokumenter og links

10.1016/j.ygyno.2020.06.040

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Citationsformater

Swisher, E. M., Coleman, R. L., Bookman, M. A., Brady, M. F., Fleming, G. F., Friedlander, M., Cunningham, M. J., Tewari, K. S., Edraki, B., Moxley, K., Mantia-Smaldone, G. M., Ratajczak, C., Dinh, M. H., Sullivan, D. M., McClain, S., Okubo, S., Steffensen, K. D., & Aghajanian, C. (2020). Safety of veliparib in combination with chemotherapy and as maintenance in front-line ovarian cancer: Results in BRCAm, hrd, and whole populations from the velia trial. Gynecologic Oncology, 159(Suppl. 1), 20-21. Artikel 37. https://doi.org/10.1016/j.ygyno.2020.06.040

@article{539057a3b9744e71aad85be200b0af3d,

title = "Safety of veliparib in combination with chemotherapy and as maintenance in front-line ovarian cancer: Results in BRCAm, hrd, and whole populations from the velia trial",

author = "Swisher, \{E. M.\} and Coleman, \{R. L.\} and Bookman, \{M. A.\} and Brady, \{M. F.\} and Fleming, \{G. F.\} and M. Friedlander and Cunningham, \{M. J.\} and Tewari, \{K. S.\} and B. Edraki and K. Moxley and Mantia-Smaldone, \{G. M.\} and C. Ratajczak and Dinh, \{M. H.\} and Sullivan, \{D. M.\} and S. McClain and S. Okubo and Steffensen, \{K. D.\} and C. Aghajanian",

year = "2020",

month = oct,

day = "1",

doi = "10.1016/j.ygyno.2020.06.040",

language = "English",

volume = "159",

pages = "20--21",

journal = "Gynecologic Oncology",

issn = "0090-8258",

publisher = "Elsevier",

number = "Suppl. 1",

note = "51st Annual Meeting of the Society of Gynecologic Oncology ; Conference date: 28-03-2020",

}

Swisher, EM, Coleman, RL, Bookman, MA, Brady, MF, Fleming, GF, Friedlander, M, Cunningham, MJ, Tewari, KS, Edraki, B, Moxley, K, Mantia-Smaldone, GM, Ratajczak, C, Dinh, MH, Sullivan, DM, McClain, S, Okubo, S, Steffensen, KD & Aghajanian, C 2020, 'Safety of veliparib in combination with chemotherapy and as maintenance in front-line ovarian cancer: Results in BRCAm, hrd, and whole populations from the velia trial', Gynecologic Oncology, bind 159, nr. Suppl. 1, 37, s. 20-21. https://doi.org/10.1016/j.ygyno.2020.06.040

Safety of veliparib in combination with chemotherapy and as maintenance in front-line ovarian cancer: Results in BRCAm, hrd, and whole populations from the velia trial. / Swisher, E. M.; Coleman, R. L.; Bookman, M. A. et al.
I: Gynecologic Oncology, Bind 159, Nr. Suppl. 1, 37, 01.10.2020, s. 20-21.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

TY - ABST

T1 - Safety of veliparib in combination with chemotherapy and as maintenance in front-line ovarian cancer: Results in BRCAm, hrd, and whole populations from the velia trial

AU - Swisher, E. M.

AU - Coleman, R. L.

AU - Bookman, M. A.

AU - Brady, M. F.

AU - Fleming, G. F.

AU - Friedlander, M.

AU - Cunningham, M. J.

AU - Tewari, K. S.

AU - Edraki, B.

AU - Moxley, K.

AU - Mantia-Smaldone, G. M.

AU - Ratajczak, C.

AU - Dinh, M. H.

AU - Sullivan, D. M.

AU - McClain, S.

AU - Okubo, S.

AU - Steffensen, K. D.

AU - Aghajanian, C.

PY - 2020/10/1

Y1 - 2020/10/1

U2 - 10.1016/j.ygyno.2020.06.040

DO - 10.1016/j.ygyno.2020.06.040

M3 - Conference abstract in journal

SN - 0090-8258

VL - 159

SP - 20

EP - 21

JO - Gynecologic Oncology

JF - Gynecologic Oncology

IS - Suppl. 1

M1 - 37

T2 - 51st Annual Meeting of the Society of Gynecologic Oncology

Y2 - 28 March 2020

ER -